Royal Bank of Canada’s Zymergen Inc. Common Stock ZY Stock Holding History

Royal Bank of Canada’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,493	Closed	-$4K	–	8181
2022 Q3	$4K	Buy	+1,493	New	+$3.62K	﹤0.01%	6857
2022 Q2	–	Sell	-4,926	Closed	-$14K	–	8136
2022 Q1	$14K	Sell	4,926 -10,779	-69%	-$45.8K	﹤0.01%	6819
2021 Q4	$105K	Buy	15,705 +13,144	+513%	+$128K	﹤0.01%	5902
2021 Q3	$34K	Buy	2,561 +1,280	+100%	+$27.2K	﹤0.01%	6393
2021 Q2	$51K	Buy	+1,281	New	+$50.6K	﹤0.01%	6030

Royal Bank of Canada's ZY Position: Q4 2022 in Review

Royal Bank of Canada sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 1,493 shares — an estimated $4K sold.

Royal Bank of Canada first reported a position in ZY in Q2 2021 and held it in 5 quarters. The position peaked at $105K in Q4 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

Royal Bank of Canada reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Royal Bank of Canada sold 1,493 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $4K.
Royal Bank of Canada first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Royal Bank of Canada's Zymergen Inc. Common Stock position peaked at $105K in Q4 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Royal Bank of Canada's 13F filing for Q4 2022, filed 14 Feb 2023.